Department of Biobehavioral Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois.
Department of Medicine, College of Medicine, University of Illinois Chicago, Chicago, Illinois; School of Public Health, University of Nevada, Reno, Reno, Nevada.
Am J Kidney Dis. 2024 Feb;83(2):208-215. doi: 10.1053/j.ajkd.2023.06.009. Epub 2023 Sep 21.
RATIONALE & OBJECTIVE: Frailty is common in individuals with chronic kidney disease (CKD) and increases the risk of adverse outcomes in adults with kidney failure requiring dialysis. However, this relationship has not been thoroughly evaluated among those with non-dialysis-dependent CKD.
Prospective cohort study.
SETTING & PARTICIPANTS: 2,539 adults in the Chronic Renal Insufficiency Cohort Study.
Frailty status assessed using 5 criteria: slow gait speed, muscle weakness, low physical activity, exhaustion, and unintentional weight loss.
Atherosclerotic events, incident heart failure, all-cause death, and cardiovascular death.
Cause-specific hazards models.
At study entry, the participants' mean age was 62 years, 46% were female, the mean estimated glomerular filtration rate was 45.4mL/min/1.73m, and the median urine protein was 0.2mg/day. Frailty status was as follows: 12% frail, 51% prefrail, and 37% nonfrail. Over a median follow-up of 11.4 years, there were 393 atherosclerotic events, 413 heart failure events, 497 deaths, and 132 cardiovascular deaths. In multivariable regression analyses, compared with nonfrailty, both frailty and prefrailty status were each associated with higher risk of an atherosclerotic event (HR, 2.03 [95% CI, 1.41-2.91] and 1.77 [95% CI, 1.35-2.31], respectively) and incident heart failure (HR, 2.22 [95% CI, 1.59-3.10] and 1.39 [95% CI, 1.07-1.82], respectively), as well as higher risk of all-cause death (HR, 2.52 [95% CI, 1.84-3.45] and 1.76 [95% CI, 1.37-2.24], respectively) and cardiovascular death (HR, 3.01 [95% CI, 1.62-5.62] and 1.78 [95% 1.06-2.99], respectively).
Self-report of aspects of the frailty assessment and comorbidities, which may have led to bias in some estimates.
In adults with CKD, frailty status was associated with higher risk of cardiovascular events and mortality. Future studies are needed to evaluate the impact of interventions to reduce frailty on cardiovascular outcomes in this population.
PLAIN-LANGUAGE SUMMARY: Frailty is common in individuals with chronic kidney disease (CKD) and increases the risk of adverse outcomes. We sought to evaluate the association of frailty status with cardiovascular events and death in adults with CKD. Frailty was assessed according to the 5 phenotypic criteria detailed by Fried and colleagues. Among 2,539 participants in the CRIC Study, we found that 12% were frail, 51% were prefrail, and 37% were nonfrail. Frailty status was associated with an increased risk of atherosclerotic events, incident heart failure, and death.
衰弱在慢性肾脏病(CKD)患者中很常见,会增加肾衰竭需要透析的成年人发生不良结局的风险。然而,这种关系在非透析依赖性 CKD 患者中尚未得到充分评估。
前瞻性队列研究。
慢性肾功能不全队列研究中的 2539 名成年人。
使用 5 项标准评估虚弱状态:缓慢的步态速度、肌肉无力、体力活动低、疲惫和非有意的体重减轻。
动脉粥样硬化事件、心力衰竭新发、全因死亡和心血管死亡。
特定原因的危害模型。
在研究开始时,参与者的平均年龄为 62 岁,46%为女性,估计肾小球滤过率平均值为 45.4mL/min/1.73m,中位数尿蛋白为 0.2mg/天。虚弱状态如下:12%为虚弱,51%为虚弱前期,37%为非虚弱。在中位随访 11.4 年期间,发生了 393 例动脉粥样硬化事件、413 例心力衰竭事件、497 例死亡和 132 例心血管死亡。在多变量回归分析中,与非虚弱相比,虚弱和虚弱前期状态与更高的动脉粥样硬化事件风险相关(HR,2.03[95%CI,1.41-2.91]和 1.77[95%CI,1.35-2.31])和新发心力衰竭(HR,2.22[95%CI,1.59-3.10]和 1.39[95%CI,1.07-1.82]),以及更高的全因死亡风险(HR,2.52[95%CI,1.84-3.45]和 1.76[95%CI,1.37-2.24])和心血管死亡风险(HR,3.01[95%CI,1.62-5.62]和 1.78[95%CI,1.06-2.99])。
虚弱评估和合并症的某些方面是自我报告的,这可能导致一些估计存在偏差。
在 CKD 患者中,虚弱状态与心血管事件和死亡率的风险增加相关。需要进一步的研究来评估减少虚弱的干预措施对该人群心血管结局的影响。